Listed

Colgate Palmolive Co: Form 10-Q for the period ended Mar 31, 2021

Filed with the SEC on Apr 30, 2021 and accepted by EDGAR at Apr 30, 2021, 08:59 ET.

Share

Management's discussion and analysis

As filed, 1,978 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

On June 18, 2018, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2018 Program”), which replaced a previously authorized share repurchase program. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The following table shows the stock repurchase activity for the three months in the quarter ended March 31, 2021:

Month Total Number of Shares Purchased(1) Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2) Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(3) (in millions)
January 1 through 31, 2021 1,500,733 $80.87 1,456,830 $1,711
February 1 through 28, 2021 1,405,641 $78.18 1,348,000 $1,606
March 1 through 31, 2021 1,777,283 $76.21 1,748,200 $1,472
Total 4,683,657 $78.29 4,553,030

(1) Includes share repurchases under the 2018 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.

(2) The difference between the total number of shares purchased and the total number of shares purchased as part of publicly

announced plans or programs is 130,627 shares, which represents shares deemed surrendered to the Company to satisfy

certain employee elections under the Company’s compensation and benefit programs.

(3) Includes approximate dollar value of shares that were available to be purchased under the publicly announced plans or programs that were in effect as of March 31, 2021.

Risk factors

As filed, 182 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes from the risk factors disclosed in Part 1, Item 1A. Risk Factors of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-01-01 to 2021-03-31$4.34bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2021-01-01 to 2021-03-31$1.71bnus-gaap:CostOfRevenue
Gross profit3 months2021-01-01 to 2021-03-31$2.64bnus-gaap:GrossProfit
Selling, general and administrative3 months2021-01-01 to 2021-03-31$1.60bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2021-01-01 to 2021-03-31$1.00bnus-gaap:OperatingIncomeLoss
Income tax3 months2021-01-01 to 2021-03-31$229.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-01-01 to 2021-03-31$681.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-01-01 to 2021-03-31$0.80us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-01-01 to 2021-03-31$0.80us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-01-01 to 2021-03-31851,400,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2021-01-01 to 2021-03-31$598.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2021-01-01 to 2021-03-31$107.0mus-gaap:PaymentsToAcquireProductiveAssets
Share repurchases3 months2021-01-01 to 2021-03-31$372.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2021-03-31$995.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-03-31$4.56bnus-gaap:AssetsCurrent
Total assetsAt period end2021-03-31$15.80bnus-gaap:Assets
Current liabilitiesAt period end2021-03-31$4.54bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-03-31$15.14bnus-gaap:Liabilities
Long-term debtAt period end2021-03-31$7.57bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2021-03-31$9.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2021-03-31$262.0mus-gaap:StockholdersEquity
Shares outstandingAt period end2021-03-31845,968,780 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000021665-21-000010. Last ingested by Listed: Nov 13, 2026, 16:05 ET. Listed shows no prices and gives no investment advice.